4/A

PRIMARY DOCUMENT

Company: FILANA THERAPEUTICS, INC.
Filed: June 14, 2005
Period of Report: May 31, 2005
Accession Number: 0001245261-05-000012

View Document ↗ View on SEC.gov ↗